Blocking the CD28-B7 T Cell Costimulation Pathway Induces Long Term Cardiac Allograft Acceptance in the Absence of IL-4

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2443-2448

  Lakkis, Fadi G ^a,e   Konieczny, Bogumila T ^a   Saleem, Sohail ^a   Baddoura, Fady K ^b   Linsley, Peter S ^c   Alexander, Dianne Z ^a   Lowry, Robin P ^d   Pearson, Thomas C ^a   Larsen, Christian P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ALLOANTIGEN; ANTIBODY CONJUGATE; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; MESSENGER RNA;

ACUTE DISEASE; ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SPLEEN; TH2 CELL; TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SPLEEN; TH2 CELLS;

EID: 0031091771     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
2. Mossman, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
3. Mossman, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
4. Takeuchi, T., R. P. Lowry, and B. Konieczny. 1992. Heart allografts in murine systems. Transplantation 53:1281.
5. Dallman, M. J. 1995. Cytokines and transplantation. Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr. Opin. Immunol. 7:632.
6. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.
7. Kupiec-Weglinski, J. W., B. Wasowska, I. Papp, G. Schmidbauer, M. H. Sayegh, W. M. Baldwin, III, K. J. Wieder, and W. W. Hancock. 1993. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J. Immunol. 151:5053.
8. Donckier, V., M. Wissing, C. Bruyns, D. Abramowicz, M. Lybin, M. Vanderhaeghen, and M. Goldman. 1995. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 59:1571.
9. Chen, N., Q. Gao, and E. H. Field. 1996. Prevention of Th1 responses is critical for tolerance. Transplantation 61:1076.
10. Maeda, H., M. Takata, S. Takahashi, S. Ogoshi, and S. Fujimoto. 1994. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse. Int. Immunol. 6:855.
11. Fanslow, W. C., K. N. Clifford, L. S. Park, A. S. Rubin, R. F. Voice, M. P. Beckman, and M. B. Widmer. 1991. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J. Immunol. 147:535.
12. Maliszewski, C. R., P. J. Morrissey, W. C. Fanslow, T. A. Sato, C. Willis, and B. Davison. 1992. Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. Cell. Immunol. 143:434.
13. Vossen, A. C. T. M., G. J. M. Tibbe, R. Benner, and H. F. J. Savelkoul. 1995. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice. Transplant. Proc. 27:380.
14. Saleem, S., B. T. Konieczny, R. P. Lowry, F. K. Baddoura, and F. G. Lakkis. 1996. Acute rejection of vascularized heart allografts in the absence of IFN. Transplantation. In press.
15. Steiger, B., P. W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T. B. Strom. 1995. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155:489.
16. Nickerson, P. W., X. X. Zheng, J. Steiger, A. W. Steele, W. Steurer, P. Roy-Chaudhury, W. Muller, and T. B. Strom. 1996. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transplant. Immunol. 4:81.
17. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag, W. Brady, M. G. Gibson, P. S. Linsley, and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
18. Pearson, T. C., D. Z. Alexander, K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701.
19. K, and non H-2 Ag. Transplantation 16:343.
20. Billingham, M. E., N. R. B. Cary, M. E. Hammond, J. Kemnitz, C. Marboe, H. A. McCallister, D. C. Snovar, G. L. Winters, and A. Zerbe. 1990. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J. Heart Transplant. 9:587.
21. Kingston, R. E. 1994. Guanidinium method for total RNA preparation. In Current Protocols in Immunology, Vol. 2. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 10.11.5.
22. Hathcock, K. S. 1994. Isolation of mouse mononuclear cells. In Current Protocols in Immunology, Vol. 1. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Wiley, New York, p. 3.1.1.
23. Lin, H., S. F. Bolling, P. S. Linsley, R-Q. Wei, D. Gordon, C. B. Thompson, and L. A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J. Exp. Med. 178:1801.
24. Kopf, M., G. L. Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
25. Shimoda, K., J. V. Deursen, M. Y. Sangster, S. R. Sarawart, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted stato gene. Nature 380:630.
26. Lee, M-S., L. Wogensen, J. Shizuru, M. B. Oldstone, and N. Sarvetnick. 1994. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93:1332.
27. Zheng, X. X., A. W. Steele, P. W. Nickerson, W. Steurer, J. Steiger, and T. B. Strom. 1995. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol. 154:5590.
28. Lowry, R. P., B. Konieczny, D. Alexander, C. Larsen, T. Pearson, S. Smith, and S. Narula. 1995. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Transplant. Proc. 27:392.
29. Chen, W-F., and A. Zlotnik. 1991. IL-10: a novel cytotoxic T-cell differentiation factor. J. Immunol. 147:528.
30. Berman, R., T. Suzuki, H. Tahara, P. Robbins, S. Narula, and M. Lotze. 1996. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. J. Immunol. 157:231.
31. + T cells. J. Exp. Med. 184:19.
32. Schwartz, R. H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1.
33. Blancho, G., P. Gianello, S. Germana, M. Baetscher, D. H. Sachs, and C. LeGuern. 1995. Molecular identification of porcine interleukin-10: regulation of expression in a kidney allograft model. Proc. Natl. Acad. Sci. USA 92:2800.
34. Larsen, C., E. Elwood, D. Alexander, S. Ritchie, R. Hendrix, C. Tucker-Burden, H.-R. Cho, A. Aruffo, D Hollenbaugh, P. Linsley, K. Winn, and T. Pearson. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
35. Garside, P., M. Steel, E. A. Worthey, A. Satoskar, J. Alexander, H. Bluethmann, F. Y. Liew, and A. M. Mowat. 1995. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154:5649.
36. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728.
37. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" tolerance. Science 259:974.
38. Davies, J. D., G. Martin, J. Phillips, S. E. Marshall, S. P. Cobbold, and H. Waldmann. 1996. T cell regulation in adult transplantation tolerance. J. Immunol. 157:529.
39. Josien, R., C. Pannetier, P. Douillard, D. Cantarovich, S. Menoret, L. Bugeon, P. Kourilsky, J-P. Soulillou, and M-C. Cuturi. 1995. Graft infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 60:1131.